Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie
From The Wire: Senior markets reporter Jonathon Davidson sat down with Paradigm Biopharmaceuticals chief executive officer Paul Rennie.
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| GLS | Ann: Weekly Net Tangible Asset Backing | 10/12/25 | 0 | 107 | |||
|
|||||||
| GLS | Ann: Monthly Investment Update and NTA Report | 09/12/25 | 0 | 130 | |||
|
|||||||
| GLS | Ann: Open of Entitlement Offer | 09/12/25 | 0 | 133 | |||
|
|||||||
| GLS | Ann: Proposed issue of securities - GLS | 04/12/25 | 0 | 108 | |||
|
|||||||
| GLS | Ann: Shortfall Offer Bookbuild Closes and Placement | 04/12/25 | 0 | 146 | |||
|
|||||||
| GLS | Ann: Investor Presentation | 04/12/25 | 1 | 421 | |||
|
|||||||
| GLS | Ann: Change of ASX Ticker | 03/12/25 | 0 | 119 | |||
|
|||||||
| GLS | Ann: Appendix 3B - Proposed Issue of Securities | 02/12/25 | 0 | 103 | |||
|
|||||||
See All Discussions
Timeline
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
| View More | |||||
ASX News